Case Reports
doi: 10.1111/j.1528-1167.2011.03304.x. Epub 2011 Nov 2.A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA)
Affiliations
- PMID:22050443
- DOI: 10.1111/j.1528-1167.2011.03304.x
Item in Clipboard
Case Reports
A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA)
Laura L Klitten et al. Epilepsia.2011 Dec.
Free article Display options
Format
Display options
Format
Abstract
Epilepsy with myoclonic absences (EMA) is a rare form of generalized epilepsy occurring in childhood and is often difficult to treat. The underlying etiology of EMA is unknown in the majority of patients. Herein, we describe a patient with EMA and intellectual disability who carries a de novo balanced translocation: t(6;22)(p21.32;q11.21). We mapped the translocation breakpoints by fluorescence in situ hybridization (FISH), and the breakpoint at 6p21.32 was found to truncate the N-methyl-d-aspartate (NMDA)-receptor associated gene SYNGAP1. The breakpoint at 22q11.21 was within a highly variable region without known protein-coding genes. Mutations of SYNGAP1 are associated with nonsyndromal intellectual disability (NSID). Two-thirds of the patients described so far also have generalized epilepsy. This finding, together with our report, suggests that dysfunction of SYNGAP1 contributes to the development of generalized epilepsy, including EMA.
Wiley Periodicals, Inc. © 2011 International League Against Epilepsy.
Similar articles
- 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment.Writzl K, Knegt AC.Writzl K, et al.Am J Med Genet A. 2013 Jul;161A(7):1682-5. doi: 10.1002/ajmg.a.35930. Epub 2013 May 17.Am J Med Genet A. 2013.PMID:23687080
- Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.Berryer MH, Hamdan FF, Klitten LL, Møller RS, Carmant L, Schwartzentruber J, Patry L, Dobrzeniecka S, Rochefort D, Neugnot-Cerioli M, Lacaille JC, Niu Z, Eng CM, Yang Y, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, Di Cristo G.Berryer MH, et al.Hum Mutat. 2013 Feb;34(2):385-94. doi: 10.1002/humu.22248. Epub 2012 Dec 12.Hum Mutat. 2013.PMID:23161826
- De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism.Hamdan FF, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs MO, Joober R, Lacaille JC, Nadeau A, Milunsky JM, Wang Z, Carmant L, Mottron L, Beauchamp MH, Rouleau GA, Michaud JL.Hamdan FF, et al.Biol Psychiatry. 2011 May 1;69(9):898-901. doi: 10.1016/j.biopsych.2010.11.015. Epub 2011 Jan 15.Biol Psychiatry. 2011.PMID:21237447
- SYNGAP1 mutations: Clinical, genetic, and pathophysiological features.Agarwal M, Johnston MV, Stafstrom CE.Agarwal M, et al.Int J Dev Neurosci. 2019 Nov;78:65-76. doi: 10.1016/j.ijdevneu.2019.08.003. Epub 2019 Aug 24.Int J Dev Neurosci. 2019.PMID:31454529Review.
- Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms.Kimura Y, Akahira-Azuma M, Harada N, Enomoto Y, Tsurusaki Y, Kurosawa K.Kimura Y, et al.Congenit Anom (Kyoto). 2018 Nov;58(6):188-190. doi: 10.1111/cga.12273. Epub 2018 Feb 13.Congenit Anom (Kyoto). 2018.PMID:29381230Review.
Cited by
- De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability.Parker MJ, Fryer AE, Shears DJ, Lachlan KL, McKee SA, Magee AC, Mohammed S, Vasudevan PC, Park SM, Benoit V, Lederer D, Maystadt I, Study D, FitzPatrick DR.Parker MJ, et al.Am J Med Genet A. 2015 Oct;167A(10):2231-7. doi: 10.1002/ajmg.a.37189. Epub 2015 Jun 15.Am J Med Genet A. 2015.PMID:26079862Free PMC article.
- Adult Phenotype ofSYNGAP1-DEE.Rong M, Benke T, Zulfiqar Ali Q, Aledo-Serrano Á, Bayat A, Rossi A, Devinsky O, Qaiser F, Ali AS, Fasano A, Bassett AS, Andrade DM.Rong M, et al.Neurol Genet. 2023 Nov 17;9(6):e200105. doi: 10.1212/NXG.0000000000200105. eCollection 2023 Dec.Neurol Genet. 2023.PMID:38045990Free PMC article.
- Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis.Kozol RA, Cukier HN, Zou B, Mayo V, De Rubeis S, Cai G, Griswold AJ, Whitehead PL, Haines JL, Gilbert JR, Cuccaro ML, Martin ER, Baker JD, Buxbaum JD, Pericak-Vance MA, Dallman JE.Kozol RA, et al.Hum Mol Genet. 2015 Jul 15;24(14):4006-23. doi: 10.1093/hmg/ddv138. Epub 2015 Apr 16.Hum Mol Genet. 2015.PMID:25882707Free PMC article.
- Next-Generation Sequencing in Korean Children With Autism Spectrum Disorder and Comorbid Epilepsy.Lee J, Ha S, Lee ST, Park SG, Shin S, Choi JR, Cheon KA.Lee J, et al.Front Pharmacol. 2020 May 14;11:585. doi: 10.3389/fphar.2020.00585. eCollection 2020.Front Pharmacol. 2020.PMID:32477112Free PMC article.
- Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice.Nakajima R, Takao K, Hattori S, Shoji H, Komiyama NH, Grant SGN, Miyakawa T.Nakajima R, et al.Neuropsychopharmacol Rep. 2019 Sep;39(3):223-237. doi: 10.1002/npr2.12073. Epub 2019 Jul 19.Neuropsychopharmacol Rep. 2019.PMID:31323176Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials